Vendor review
Yiwu Aozuo Trading Co reviews
Yiwu Aozuo Trading Co reviews from 146 independent lab tests (Retatrutide, Tirzepatide and BPC-157): grade A, purity and fill accuracy. Is Yiwu Aozuo Trading Co legit? See what its vials showed.
What the lab tests show
146 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 9, 2026 | GHK-Cu | 99.9 % | 49.99 mg of 50 mg (0 %) | Pass | View |
| Oct 6, 2026 | BPC-157 | 97.69 % | 5.16597 mg of 5 mg (3 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 100 % | 19.311 mg of 15 mg (29 %) | Pass | View |
| Sep 16, 2026 | Tirzepatide | 100 % | 43.46 mg of 40 mg (9 %) | Pass | View |
| Sep 16, 2026 | Tirzepatide | 93.85 % | 57.3871 mg of 40 mg (43 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 100 mg | Fail | View | |
| Sep 15, 2026 | BPC-157 | 84.6 % | 8.46 mg of 10 mg (-15 %) | Pass | View |
| Sep 15, 2026 | Retatrutide | 99.9 % | 13.5 mg of 15 mg (-10 %) | Pass | View |
| Sep 14, 2026 | Sermorelin | 99.4 % | 4.43 mg of 5 mg (-11 %) | Pass | View |
| Sep 10, 2026 | Tesamorelin | 98.6 % | 9.13 mg of 10 mg (-9 %) | Pass | View |
| Sep 10, 2026 | Ipamorelin | 99.2 % | 5 mg of 5 mg (0 %) | Pass | View |
| Sep 9, 2026 | GHK-Cu | 99.9 % | 47.5 mg of 50 mg (-5 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 99.9 % | 14.8 mg of 15 mg (-1 %) | Pass | View |
| Sep 8, 2026 | Tirzepatide | 99.9 % | 24.3 mg of 20 mg (22 %) | Pass | View |
| Sep 7, 2026 | Tirzepatide | 99.7 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Aug 31, 2026 | Tirzepatide | 99.8 % | 33.6 mg of 30 mg (12 %) | Pass | View |
| Aug 21, 2026 | Tesamorelin | 99.7 % | 13 mg of 10 mg (30 %) | Pass | View |
| Aug 3, 2026 | TB-500 | 99.9 % | 9.34 mg of 10 mg (-7 %) | Pass | View |
| Jul 23, 2026 | Tesamorelin | 98.5 % | 9.86 mg of 10 mg (-1 %) | Pass | View |
| Jul 22, 2026 | Ipamorelin | 99.7 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jul 13, 2026 | Tesamorelin | 98.1 % | 11 mg of 10 mg (10 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 99.6 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 50 mg | Fail | View | |
| Jul 9, 2026 | Retatrutide | 99.2 % | 8.6 mg of 10 mg (-14 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 99.9 % | 4.49 mg of 5 mg (-10 %) | Pass | View |
| Jun 24, 2026 | Ipamorelin | 99.6 % | 4.88 mg of 5 mg (-2 %) | Pass | View |
| Jun 12, 2026 | GHK-Cu | 99.9 % | 94.9 mg of 100 mg (-5 %) | Pass | View |
| Jun 8, 2026 | BPC-157 | 99.4 % | 5.21 mg of 5 mg (4 %) | Pass | View |
| May 20, 2026 | PT-141 | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| May 13, 2026 | Tirzepatide | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Apr 26, 2026 | BPC-157 | 96.4 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Mar 25, 2026 | Tesamorelin | 99.8 % | 6.5 mg of 5 mg (30 %) | Pass | View |
| Mar 25, 2026 | TB-500 | 99.6 % | 5 mg of 5 mg (0 %) | Pass | View |
| Mar 25, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Mar 21, 2026 | GHK-Cu | 99.7 % | 50.6 mg of 50 mg (1 %) | Pass | View |
| Mar 21, 2026 | Cagrilintide | 99.8 % | 5.9 mg of 5 mg (18 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 95.3 % | 24.3 mg of 30 mg (-19 %) | Pass | View |
| Mar 16, 2026 | Retatrutide | 99.9 % | 15.4 mg of 15 mg (3 %) | Pass | View |
| Mar 10, 2026 | GHK-Cu | 99.9 % | 42.3 mg of 50 mg (-15 %) | Pass | View |
| Mar 10, 2026 | Tirzepatide | 99.9 % | 29.8 mg of 30 mg (-1 %) | Pass | View |
| Mar 7, 2026 | GHK-Cu | 99.6 % | 47.3 mg of 50 mg (-5 %) | Pass | View |
| Mar 6, 2026 | Tesamorelin | 99.7 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 6, 2026 | Ipamorelin | 99.9 % | 4.63 mg of 5 mg (-7 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Mar 2, 2026 | Ipamorelin | 99.7 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 14.8 mg of 15 mg (-1 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 27.9 mg of 30 mg (-7 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.87 % | 98 mg of 100 mg (-2 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.36 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.77 % | 32.1 mg of 30 mg (7 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.6 % | 4.68 mg of 5 mg (-6 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 98.44 % | 14.5 mg of 15 mg (-3 %) | Pass | View |
| Feb 25, 2026 | Tirzepatide | 99.88 % | 62.9 mg of 60 mg (5 %) | Pass | View |
| Feb 25, 2026 | Tirzepatide | 99.76 % | 58.2 mg of 60 mg (-3 %) | Pass | View |
| Feb 15, 2026 | Tirzepatide | 99.8 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.7 % | 16.5 mg of 15 mg (10 %) | Pass | View |
| Feb 9, 2026 | Retatrutide | 99.9 % | 5.09 mg of 5 mg (2 %) | Pass | View |
| Feb 9, 2026 | Retatrutide | 99.9 % | 39 mg of 36 mg (8 %) | Pass | View |
| Feb 4, 2026 | TB-500 | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 99.9 % | 43.6 mg of 50 mg (-13 %) | Pass | View |
What Yiwu Aozuo Trading Co sells
No current listings on record.
About Yiwu Aozuo Trading Co
Finnrick has tested 146 samples from Yiwu Aozuo Trading Co across 11 products.